Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

University of Alabama at Birmingham

University of Alabama at Birmingham in Birmingham, Alabama, United States is listed as a site for 2,097 registered clinical trials, 556 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 2,097
Ongoing 556

This page covers the site record University of Alabama at Birmingham in Birmingham, Alabama, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, University of Alabama at Birmingham, also sponsors trials.

Get the University of Alabama at Birmingham report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 2,097 trials counted.

  • Phase 1 189 trials
  • Phase 1/2 93 trials
  • Phase 2 382 trials
  • Phase 2/3 46 trials
  • Phase 3 398 trials
  • Phase 4 98 trials
  • Not applicable 584 trials
  • Observational 297 trials
  • Expanded access 9 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 562 trials
  • Completed 1,225 trials
  • Terminated 278 trials
  • Other 32 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Unknown)

Top of scale: 133

1993: 2 trials (Observational 1, Phase 3 1) 1996: 3 trials (Observational 1, Not applicable 1, Phase 3 1) 1997: 2 trials (Phase 3 1, Phase 2 1) 1998: 5 trials (Observational 1, Phase 3 3, Phase 2/3 1) 1999: 9 trials (Observational 1, Phase 3 5, Phase 2 2, Phase 1/2 1) 2000: 11 trials (Observational 1, Not applicable 2, Phase 3 5, Phase 2 2, Phase 1/2 1) 2001: 14 trials (Observational 4, Not applicable 2, Phase 4 1, Phase 3 2, Phase 2 3, Phase 1/2 1, Phase 1 1) 2002: 24 trials (Not applicable 3, Phase 4 1, Phase 3 7, Phase 2 5, Phase 1/2 6, Phase 1 2) 2003: 29 trials (Observational 4, Not applicable 5, Phase 4 3, Phase 3 8, Phase 2 5, Phase 1/2 1, Phase 1 3) 2004: 33 trials (Observational 4, Not applicable 4, Phase 4 6, Phase 3 6, Phase 2/3 1, Phase 2 8, Phase 1 4) 2005: 47 trials (Observational 5, Not applicable 10, Phase 4 1, Phase 3 13, Phase 2/3 1, Phase 2 8, Phase 1/2 5, Phase 1 4) 2006: 53 trials (Observational 10, Not applicable 3, Phase 4 1, Phase 3 18, Phase 2/3 1, Phase 2 10, Phase 1/2 4, Phase 1 6) 2007: 57 trials (Observational 10, Not applicable 6, Phase 4 3, Phase 3 13, Phase 2/3 3, Phase 2 13, Phase 1/2 3, Phase 1 6) 2008: 71 trials (Observational 13, Not applicable 15, Phase 4 5, Phase 3 12, Phase 2/3 2, Phase 2 19, Phase 1 5) 2009: 75 trials (Observational 16, Not applicable 13, Phase 4 3, Phase 3 20, Phase 2 14, Phase 1/2 2, Phase 1 7) 2010: 75 trials (Observational 16, Not applicable 11, Phase 4 6, Phase 3 15, Phase 2/3 1, Phase 2 14, Phase 1/2 1, Phase 1 11) 2011: 73 trials (Observational 13, Not applicable 11, Phase 4 3, Phase 3 15, Phase 2/3 1, Phase 2 19, Phase 1/2 2, Phase 1 9) 2012: 67 trials (Other 1, Observational 14, Not applicable 19, Phase 4 2, Phase 3 13, Phase 2/3 1, Phase 2 15, Phase 1 2) 2013: 75 trials (Observational 6, Not applicable 15, Phase 4 3, Phase 3 16, Phase 2/3 2, Phase 2 14, Phase 1/2 7, Phase 1 12) 2014: 81 trials (Observational 19, Not applicable 14, Phase 4 2, Phase 3 16, Phase 2/3 2, Phase 2 18, Phase 1/2 3, Phase 1 7) 2015: 73 trials (Observational 13, Not applicable 18, Phase 4 2, Phase 3 8, Phase 2/3 2, Phase 2 13, Phase 1/2 5, Phase 1 12) 2016: 82 trials (Observational 10, Not applicable 31, Phase 4 3, Phase 3 17, Phase 2/3 1, Phase 2 14, Phase 1/2 1, Phase 1 5) 2017: 101 trials (Observational 13, Not applicable 22, Phase 4 5, Phase 3 27, Phase 2/3 4, Phase 2 18, Phase 1/2 4, Phase 1 8) 2018: 124 trials (Observational 10, Not applicable 38, Phase 4 11, Phase 3 29, Phase 2/3 4, Phase 2 17, Phase 1/2 7, Phase 1 8) 2019: 107 trials (Observational 19, Not applicable 28, Phase 4 6, Phase 3 18, Phase 2/3 2, Phase 2 16, Phase 1/2 3, Phase 1 15) 2020: 133 trials (Observational 19, Not applicable 43, Phase 4 8, Phase 3 21, Phase 2/3 3, Phase 2 27, Phase 1/2 2, Phase 1 10) 2021: 129 trials (Observational 16, Not applicable 41, Phase 4 7, Phase 3 18, Phase 2/3 5, Phase 2 23, Phase 1/2 6, Phase 1 13) 2022: 114 trials (Observational 14, Not applicable 43, Phase 4 4, Phase 3 18, Phase 2/3 2, Phase 2 23, Phase 1/2 7, Phase 1 3) 2023: 98 trials (Observational 12, Not applicable 43, Phase 4 1, Phase 3 11, Phase 2/3 2, Phase 2 14, Phase 1/2 6, Phase 1 9) 2024: 87 trials (Observational 7, Not applicable 39, Phase 4 3, Phase 3 15, Phase 2 10, Phase 1/2 4, Phase 1 9) 2025: 115 trials (Observational 17, Not applicable 45, Phase 4 4, Phase 3 14, Phase 2/3 1, Phase 2 20, Phase 1/2 5, Phase 1 9)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 93
2025 115
2024 87
2023 98
2022 114
2021 129
2020 133
2019 107
2018 124
2017 101

Showing 10 of 32 years.

Start your 14-day trial Email me all 32 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 16 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 2,097 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 406 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 767 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF